arsenic trioxide has been researched along with 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, RH; Friedrich, O; Körper, S; Nolte, F; Rojewski, M; Schrezenmeier, H | 1 |
| Bai, SZ; Chen, GQ; Fu, GH; Guo, ZW; Liu, XB; Wang, Y; Xi, YH; Yang, BF | 1 |
2 other study(ies) available for arsenic trioxide and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid
| Article | Year |
|---|---|
Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Membrane; Chloride Channels; Chlorides; fas Receptor; Humans; Membrane Potentials; Myeloid Cells; Nitrobenzoates; Oxides; Sodium; U937 Cells | 2004 |
As2O3 enhances the anion transport activity of band 3 and the action is related with the C-terminal 16 residues of the protein.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adult; Anion Exchange Protein 1, Erythrocyte; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Erythrocytes; Female; Gene Deletion; HeLa Cells; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Male; Oxides; Transfection; Yeasts | 2005 |